Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma.

Mellinghoff IK, Ellingson BM, Touat M, Maher E, De La Fuente MI, Holdhoff M, Cote GM, Burris H, Janku F, Young RJ, Huang R, Jiang L, Choe S, Fan B, Yen K, Lu M, Bowden C, Steelman L, Pandya SS, Cloughesy TF, Wen PY

Open source

DOI: 10.1200/jco.19.03327
Published: 2020 Oct 10
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.19.03327,
  title = {Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma.},
  author = {Mellinghoff IK and Ellingson BM and Touat M and Maher E and De La Fuente MI and Holdhoff M and Cote GM and Burris H and Janku F and Young RJ and Huang R and Jiang L and Choe S and Fan B and Yen K and Lu M and Bowden C and Steelman L and Pandya SS and Cloughesy TF and Wen PY},
  year = {2020},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco.19.03327},
  url = {https://doi.org/10.1200/jco.19.03327}
}

RIS

TY  - JOUR
TI  - Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma.
AU  - Mellinghoff IK
AU  - Ellingson BM
AU  - Touat M
AU  - Maher E
AU  - De La Fuente MI
AU  - Holdhoff M
AU  - Cote GM
AU  - Burris H
AU  - Janku F
AU  - Young RJ
AU  - Huang R
AU  - Jiang L
AU  - Choe S
AU  - Fan B
AU  - Yen K
AU  - Lu M
AU  - Bowden C
AU  - Steelman L
AU  - Pandya SS
AU  - Cloughesy TF
AU  - Wen PY
PY  - 2020
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco.19.03327
UR  - https://doi.org/10.1200/jco.19.03327
ER  -

APA

IK, M., BM, E., M, T., E, M., MI, D. L. F., M, H., GM, C., H, B., F, J., RJ, Y., R, H., L, J., S, C., B, F., K, Y., M, L., C, B., L, S., SS, P., TF, C., & PY, W. (2020). Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.19.03327

Source records

pubmed · retrieved 2026-09-27T09:47:21.224Z